JAMA Network Home
Sign In
Original Investigation

Inflammatory Bowel Disease and Interleukin-17 Inhibitors in Hidradenitis Suppurativa

JAMA Dermatology 10.1001/jamadermatol.2026.3373

September 09, 2026 at 11:00 AM EDT

Read the full article

This systematic review and meta-analysis evaluates the incidence of inflammatory bowel disease in patients with hidradenitis suppurativa treated with interleukin-17 inhibitors.

Corresponding Author: Ahuva Cices, MD, Department of Dermatology, Icahn School of Medicine at Mount Sinai, 5 E 98th St, New York, NY 10029 (ahuva.cices@mountsinai.org).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2026.3373?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=090926

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks